Searching journal content for articles similar to See et al. 32 (4): 629.

Displaying results 1-10 of 16
For checked items
  1. ...of H3K4me3-BD over CCND1 in the latter was associated with overexpression and extensive chromatin accessibility of its gene body. We observed similar cancer-specific H3K4me3-BDs associated with hijacking of super-enhancers of other common oncogenes in B cell (MAF, MYC, and FGFR3/NSD2) and T cell...
  2. ...subjects of duplications in cancer. For instance, distal enhancers of oncogenes such as KLF5, AR, SOX2, MYC, and EGFR are selectively duplicated with or without the oncogenes in diverse cancer types, which activates their expression through up to 800 kb long-distance enhancer–promoter interactions (Zhang...
  3. .... The green looping tracks show the gain of interactions upon global CTCF knockdown. (D) qRT-PCRs showing the levels of sense and antisense RNA from MYC gene upon their shRNA-mediated knockdowns in a chromatin-associated RNA fraction. The level of RNA at Chr 11 boundary does not change. (E) CTCF Ch...
  4. ...mutations in DICER1 and RB1 genes are known predisposing factors (de Kock et al. 2014, 2020), but also sporadic PB events are frequent with a major role for MYC amplification (Li et al. 2020; Liu et al. 2021). Moreover, DNA methylation profiling and whole-exome sequencing revealed a homozygous deletion...
  5. ...also observed extensive changes in enhancer-promoter interactions within the TAD, suggesting that it is the downstream chromatin remodeling which gives rise to the oncogene activation, rather than the presence of the inserted super-enhancer DNA sequence per se. Simulations of the IGH-CCND1 reciprocal...
  6. ...that this transcription factor regulates a complex transcriptional regulatory network, implicated in multiple cellular processes and signaling pathways (such as TNF, IL2-STAT5, KRAS, MTOR, MYC, or TP53). Out of these, we detected that genes down-regulated upon PRDM5 silencing were associated with the cell cycle as well...
  7. ...leukemias (AMLs). KMT2A-AFF1 drives leukemogenesis through direct binding and inducing the aberrant overexpression of key genes, such as the anti-apoptotic factor BCL2 and the proto-oncogene MYC. However, studying direct binding alone does not incorporate possible network-generated regulatory outputs...
  8. ...upstream of MYC. Both are associated with elevated MYC transcript levels (Fig. 2C; Supplemental Figs. S2.1, S2.2), consistent with impacts of amplification of the gene or adjacent super-enhancers (Zhang et al. 2016). HPV integration near MYC previously was reported in cervical cancers and derived cell...
  9. ...in the reporter assay. We used CRISPR to modify the endogenous sequences, establishing cell lines varying in the Alu genotype. Our findings indicate that Alu genotype can alter expression of genes implicated in cancer risk, including PTHLH, RANBP9, and MYC. These data show that commonly occurring polymorphic Alu...
  10. ...bodies, suggesting an alternative and nonrepressive function (Wang et al. 2009; Kidder and Palmer 2012; Whyte et al. 2012). In tumor cells, HDAC inhibition reduced the activity of superenhancers (SEs) via aberrant hyperacetylation, causing down-regulation of SE-driven transcription of genes such as Myc...
For checked items

Preprint Server